AI Readiness Audit — Biotech

Score how ready Biotech is to deploy practical AI — and see the highest-ROI use cases for your sector.

Where AI pays off in Biotech

AI for drug discovery and lead optimization — protein structure prediction (AlphaFold-class models), generative chemistry, target identification, and lead optimization that compresses early-discovery timelines.
AI for clinical trial design and operations — patient recruitment optimization, site selection ML, protocol design support, and trial-monitoring AI that compress the largest single cost line in R&D.
Generative AI for regulatory and medical writing — IND, NDA, CSR, and protocol drafting copilots that compress the medical-writing burden without compromising the regulator-ready quality the documents require.
AI for real-world evidence and post-market — RWE generation, post-market surveillance ML, and label-expansion analytics that lift the value of approved products beyond the original NDA.

Section 1 of 6 · Strategy & Use Cases0/18 answered

Strategy & Use Cases

Whether AI is pointed at a real, measurable business problem.

1.How clearly have you identified where AI should help?

2.Are the target outcomes measurable?

3.Is there executive sponsorship and budget?

Send us the result and the constraint behind it. We’ll scope the diagnostic, sprint, or build that fixes what the score reveals.